An AI-powered multi-biomarker biosensor system for continuous monitoring of women's reproductive health. Early detection of endometriosis, PCOS, and ovulatory disorders through real-time physiological analysis.
Millions of women suffer from undiagnosed reproductive health conditions due to the lack of continuous monitoring solutions.
EndoAI integrates cutting-edge biosensor technology with artificial intelligence to provide unprecedented insight into women's reproductive health.
Simultaneous monitoring of hormones, inflammatory markers, metabolites, and physiological signals through a single minimally-invasive chip.
TinyML models trained on thousands of patient profiles detect subtle physiological patterns months before clinical symptoms appear.
Instant notifications to both patients and physicians when anomalous patterns are detected, enabling proactive intervention.
Comprehensive clinical interface for monitoring multiple patients, reviewing trends, and generating AI-powered diagnostic reports.
End-to-end encrypted storage for all medical data, reports, and biosensor readings with HIPAA-compliant access controls.
Machine learning models forecast disease progression and treatment response based on longitudinal biosensor data.
EndoAI tracks a comprehensive panel of biomarkers to provide a complete picture of reproductive health.
Try the fully functional EndoAI prototype. Simulate biosensor readings, run AI analysis, and generate medical reports.